← Back to Clinical Trials
RecruitingNCT06979999

The Effects of Positive End-expiratory Pressure (PEEP) on Optic Nerve Sheath Diameter in Laparoscopic Cholecystectomy

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionPositive End-expiratory Pressure (PEEP)
SponsorNigde Omer Halisdemir University
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment50
SexALL
Min Age18 Years
Max Age70 Years
Start Date2024-04-29
Completion2025-05-29
Interventions
Positive End-Expiratory Pressure (PEEP)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This prospective interventional study will evaluate the effects of applying positive end-expiratory pressure (PEEP) at 10 cmH₂O on optic nerve sheath diameter (ONSD) in patients undergoing elective laparoscopic cholecystectomy under general anesthesia. A total of approximately 80 adult patients (ASA physical status I-III) will be included following informed consent. ONSD will be measured using a high-frequency linear ultrasound probe at three predefined intraoperative time points: (T0) 10 minutes after initiation of mechanical ventilation, (T1) 10 minutes after pneumoperitoneum creation, and (T2) 30 minutes after pneumoperitoneum creation. Dynamic lung compliance, peak airway pressure (Ppeak), end-tidal CO₂ (EtCO₂), heart rate, mean arterial pressure, and SpO₂ will also be recorded. The aim is to assess whether the application of PEEP influences intracranial pressure indicators, particularly ONSD, during laparoscopic procedures. The study may provide valuable insights into the neurophysiological effects of intra-abdominal pressure and mechanical ventilation strategies in surgical patients.

Eligibility Criteria

Inclusion Criteria: \- Adult patients (age ≥ 18 years) American Society of Anesthesiologists (ASA) physical status I-III Scheduled for elective laparoscopic cholecystectomy under general anesthesia Signed informed consent Exclusion Criteria: * resence of acute or chronic eye disease Uncontrolled hypertension Asthma or known chronic pulmonary disease Any neurological disorders Body mass index (BMI) \> 35 kg/m² Use of medications known to affect intracranial pressure Refusal to participate after signing informed consent

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology